Internal Medicine, Medical Oncology · Ann Arbor, MI
NPI
1245556851
Since 2010
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 E Medical Center Dr, B1 Floor Cancer Recp C
Ann Arbor, MI, 48109
Phone (734) 647-8902
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
449 services
Medicare patients, 2024
123
Average age 72
Drug cost, 2024
$626K
485 prescriptions
Company payments, 2025
$1,668
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul L Swiecicki was code 99215 (office e&m - established), 200 times for 76 patients. In total Paul L Swiecicki billed 449 services in 13 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 200 | 76 | $112.31 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 131 | 63 | $13.14 | $1,721 |
| 99205 Office E&M - New | Facility | 53 | 53 | $137.56 | $7,291 |
By year: 2022 $35K for 339 services; 2023 $37K for 341 services; 2024 $37K for 449 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul L Swiecicki prescribed most often to Medicare patients was Ondansetron Hcl, with 53 prescriptions and refills. In total Paul L Swiecicki wrote 485 Medicare prescriptions that cost $626K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 53 | 55 | 43 | $376 |
| Prochlorperazine Maleate Generic | 41 | 41 | 34 | $808 |
| Oxycodone Hcl Generic | 30 | 30 | 17 | $1,500 |
| Prednisone Generic | 26 | 30 | 14 | $283 |
| Ondansetron Odt Ondansetron | 22 | 22 | Under 11 | $569 |
| Erivedge Vismodegib | 21 | 25 | Under 11 | $334K |
| Levothyroxine Sodium Generic | 20 | 60 | Under 11 | $397 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 16 | 16 | Under 11 | $459 |
| Gabapentin Generic | 14 | 35 | Under 11 | $1,803 |
| Olanzapine Generic | 13 | 33 | Under 11 | $254 |
| Fentanyl Generic | 12 | 13 | Under 11 | $519 |
| Morphine Sulfate Generic | 12 | 12 | Under 11 | $262 |
| Omeprazole Generic | 11 | 11 | Under 11 | $103 |
Brand drugs: - claims; generic drugs: 413 claims; opioid claims: 93.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul L Swiecicki $1,668 ($1,475 in general payments such as food, travel and fees and $192 for research) from 8 companies. The largest payer was Astellas Pharma Global Development with $688.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.